Psychosomatic Medicine Faster Service from Outside North America
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pruessner, M.
Right arrow Articles by Lupien, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pruessner, M.
Right arrow Articles by Lupien, S. J.
Related Collections
Right arrow Neuroendocrine
Right arrow Sleep and Biological Rhythms
Right arrow Stress and Coping
Psychosomatic Medicine 65:92-99 (2003)
© 2003 American Psychosomatic Society


ORIGINAL ARTICLES

Self-Reported Depressive Symptoms and Stress Levels in Healthy Young Men: Associations With the Cortisol Response to Awakening

Marita Pruessner, MSc, Dirk H. Hellhammer, PhD, Jens C. Pruessner, PhD and Sonia J. Lupien, PhD

From Douglas Hospital Research Center (M.P., J.C.P., S.J.L.), McGill University, and McConnell Brain Imaging Centre (M.P., J.C.P.), Montréal Neurological Hospital, McGill University, Montréal, Canada; and the Center for Psychobiological and Psychosomatic Research (M.P., D.H.H.), University of Trier, Trier, Germany.

Address reprint requests to: Marita Pruessner, MSc, McConnell Brain Imaging Centre, Montréal Neurological Institute, 3801 University St., Suite Webster 2B, Montréal, Quebec, H3A 2B4, Canada. Email: marita{at}bic.mni.mcgill.ca


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
OBJECTIVE: There is evidence that clinical depression and negative mood are associated with elevated basal cortisol levels. Recently, measuring the cortisol response during the first hour in the morning with strict reference to the time of awakening was established as a reliable marker of individual adrenocortical activity. In studies using this marker, a relationship with self-reported stress levels and psychosomatic symptoms has been found. The goal of the present study was to investigate the association of self-reported depressive symptomatology with early morning free cortisol levels and their relationship to measures of stress.

METHODS: We assessed the severity of depressive symptoms using the Hamilton Depression Inventory and chronic and acute stress perception in 40 healthy young men. Once a week, for 4 consecutive weeks, subjects provided saliva samples collected at 0, 30, and 60 minutes after awakening.

RESULTS: Higher levels of depressive symptomatology were associated with a greater cortisol response after awakening. This association seemed to be stronger when only subjects in the nonclinical range of depression were included. Furthermore, cortisol levels and depressive symptomatology were significantly positively correlated with measures of chronic and acute stress perception.

CONCLUSIONS: The present study extends earlier findings of hypothalamus-pituitary-adrenal axis hyperactivity in clinical depression to healthy young men with mild levels of depressive symptomatology. Measuring the cortisol response to awakening is proposed as an economical alternative to traditional approaches for determining basal hypothalamus-pituitary-adrenal axis activity. Associations between depressive symptomatology and chronic stress, as well as implications for future studies, are discussed.

Key Words: depression • mood • chronic stress • hypothalamus-pituitary-adrenal axis • salivary cortisol • awakening response.

Abbreviations: ANOVA = analysis of variance; DSM-III-R = Diagnostic and Statistical Manual of Mental Disorders, 3rd edition revised; HDI = Hamilton Depression Inventory; HPA = hypothalamus-pituitary-adrenal axis; TICS = Trier Inventory for the Assessment of Chronic Stress; CRF = corticotropin-releasing factor.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Hyperactivity of the hypothalamus-pituitary-adrenal (HPA) axis in major depression has been frequently reported in recent decades (for reviews see Refs. 1 and 2). Alterations at different levels of the HPA system are believed to contribute to the observed elevation in cortisol levels. First, there seems to be an increased central drive with hypersecretion of CRF from the paraventricular nucleus of the hypothalamus (3), probably potentiated by the action of arginin vasopressin (4). Second, negative feedback control of the HPA axis is impaired in depression, probably as a result of altered capacity or function of glucocorticoid receptors (5). Using the dexamethasone suppression test as a tool to examine glucocorticoid-mediated feedback of the HPA axis, studies have shown that 50% to 60% of patients with depression (primarily severe endogenous depression) fail to display a subsequent suppression of cortisol (6, 7). Third, patients with major depression show an enlargement of the adrenal glands (8), which seems to be reversible on remission of the acute depressive episode after treatment (9). Apart from HPA dysregulations in association with clinical depression, numerous studies report negative affect in conditions characterized by hypercortisolism (1015).

Traditionally cortisol secretion in depression or negative mood is determined as a diurnal profile in plasma (1621) or urine (2224). Only a few studies have used saliva samples (2527). Some investigators have reported an association between depressive symptomatology and elevated cortisol levels especially in the morning hours (17, 21, 24, 26), whereas others have concluded that the evening cortisol levels show the highest association with depression (28).

In recent years the observation of a pronounced cortisol response to awakening (2931) has triggered a series of studies testing the usefulness of that marker to determine basal HPA regulation. Cortisol levels in saliva with strict reference to the time of awakening increased by 50% to 70% during the first 30 minutes and showed test-retest correlations (r) of 0.45 to 0.70 (32). These results clearly demonstrate higher intraindividual stability than single morning cortisol assessment or measurement at predefined times (32, 33). Several studies investigated the association of the cortisol response to awakening with psychological variables and found elevated cortisol levels 30 to 60 minutes after awakening in subjects with high levels of chronic stress during the past year (34, 35). In a similar way, perceived stress during the last month was correlated with increases of cortisol levels during the first hour after awakening after dexamethasone pretreatment (36). In contrast, a diagnosis of burnout (36) or chronic pain (37) was characterized by attenuated cortisol levels after awakening.

The above findings clearly encourage the measurement of salivary free cortisol after awakening to identify HPA hyperactivity in association with depression and negative mood. In a group of 40 healthy young men we assessed the relationship between self-reported depressive symptoms and the cortisol response to awakening and the association between depressive symptomatology and cortisol levels with measures of acute and chronic stress.


    METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Subjects
Forty healthy male university students aged 18 to 35 years (mean age = 24.3 ± 4.33) were recruited through postings on university bulletin boards. Woman were excluded from this study because of the possible confounding effects of menstrual cycle and use of oral contraceptives on HPA responsivity (38). Exclusion criteria were any history of psychiatric disorder, cardiovascular problems, and alcohol abuse. Subjects had to be medication free at the time of testing and were asked to indicate any history of chronic health problems, which were assessed to detect any factors that could affect cortisol reactivity. Six of the 40 subjects were light to moderate smokers. They reported smoking between 1 and 15 cigarettes per day. However, statistical analysis revealed that smoking was not associated with any of our dependent variables. The study was approved by the local hospital’s ethics board, and written consent was obtained from each subject before participation.

Cortisol Assessment
Cortisol was assessed from saliva collected with the Salivette sampling device (Sarstedt, Rommelsdorf, Germany). This noninvasive technique can be used at home and interferes only minimally with normal daily routines. Cortisol in saliva reliably reflects the free (unbound) fraction of cortisol in plasma (39).

Subjects collected saliva once a week (Wednesday or Thursday) for 4 consecutive weeks at 0, 30, and 60 minutes after awakening in the morning. Awakening was either spontaneous or by alarm clock. Previous studies have shown that the cortisol response is not affected by this variable (32). Subjects were asked to refrain from drinking caffeinated beverages and smoking before saliva sampling. Furthermore, they were instructed not to brush their teeth before the end of the sampling time in the morning, not to eat or drink in the 10 minutes before sampling, and to rinse their mouth with water before sampling. All psychological testing and an acute stress rating were performed within the month after cortisol assessment. The individual time delay between cortisol and psychological assessment did not create any effects.

Psychological Assessment
Depressive symptomatology.
Depressive symptomatology was assessed with the Hamilton Depression Inventory (HDI) (40), a revised and extended self-report version of the Hamilton Depression Rating Scale (41). The HDI consists of 23 items and serves as a measure of the severity of depressive symptoms. Subjects are asked to refer to their feelings and behavior during the past 2 weeks, which has become a standard on self-report measures of depression (40). According to the authors of the HDI, a cutoff score of 19 best distinguishes between nondepressed and clinically depressed persons rated with DSM-III-R criteria, whereas levels between 14 and 18.5 are regarded as subclinical and suggest a general level of psychological distress. The internal consistency reliability coefficient for the HDI is 0.93 (Cronbach’s {alpha}), and the test-retest reliability coefficient is 0.95 (Pearson product moment correlation). Criterion-related validity of the HDI was proven by high correlations (r = 0.94, p < .001) with the Hamilton Depression Rating Scale clinical interview; construct validity was demonstrated by strong correlations (r = 0.93, p < .001) with the Beck Depression Inventory.

Chronic and acute stress.
Subjective stress levels were assessed with an English version of the Trier Inventory for the Assessment of Chronic Stress (TICS) (42). The TICS is a 39-item self-report scale for the assessment of chronic stress. It consists of six scales: work overload, worries, social stress, lack of recognition, work discontent, and intrusive memories. Internal consistency coefficients for the six scales vary between 0.76 and 0.88. Subjects are asked to assess on a five-point rating scale how frequently they experienced specific stressful situations during the past year. As a measure of acute stress, subjects were asked to indicate their actual stress level on a 10-point rating scale with 1 being very low and 10 being very high.

Psychological, Endocrinological, and Statistical Analyses
The saliva samples were analyzed using a time-resolved immunoassay with fluorescence detection (43). The intra- and interassay variability was below 10% and 12%, respectively. One subject had to be excluded because of cortisol levels that were more than three standard deviations above the group mean. One subject obtained an HDI score of 36.5 (cutoff score was 19) and thus was referred to as potentially clinically depressed. Two subjects obtained a score of 19, and three subjects scored between 14 and 18.5, which corresponds to the subclinical range of depression. These subjects were excluded from analysis of the nonclinical range of depression.

To analyze the cortisol increase after awakening for the 4 sampling days, two-way within-subject ANOVAs were computed with repeated measures on the factors time (three levels) and day (four levels). To analyze the linear relationship between depressive symptoms or chronic stress and cortisol regulation, Pearson correlations were computed between the scores on the HDI and the TICS and the cortisol response after awakening. Pearson correlations were also calculated between HDI and TICS scores. Spearman rank correlations were used to determine associations between the 10-point rating scale for acute stress and HDI scores as well as cortisol levels. For all correlational analysis, cortisol levels were transformed into a single value by calculating the area under the curve for each day and then computing the median from the four individual cortisol (day) values.

Because previous studies had shown that cortisol levels 30 and 60 minutes after awakening best differentiate between groups (34, 35), the impact of cortisol levels at different times after awakening was assessed. Therefore, groups of subjects with high and low depressive symptomatology and high and low stress levels were determined by median split and entered into two-way ANOVAs (group by time) as independent variables. For the individual cortisol levels during the 4 weeks, the median was calculated for each sampling time (0, 30, and 60 minutes after awakening). These aggregated levels served as dependent variables in the ANOVA. Significant interaction effects were specified by Newman-Keuls post hoc tests.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Cortisol levels after awakening showed a highly significant increase during the first 30 minutes on all 4 sampling days (F(2,76) = 22.9, p < .001). At the time of awakening, a mean cortisol level of 17.64 nmol/liter was observed; this level increased by approximately 40% to 24.55 nmol/liter 30 minutes after awakening. The response was not significantly different between the 4 sampling days (all p values > .10). The effect size for the factor time was f2 = 0.26, explaining 21% of the variability of the cortisol response to awakening ({omega}2 = 0.21). Figure 1 illustrates the cortisol response after awakening for the three sampling times and four sampling days.



View larger version (8K):
[in this window]
[in a new window]
 
Fig. 1. Mean cortisol levels 0, 30, and 60 minutes after awakening on the 4 sampling days (1 day each for 4 consecutive weeks, N = 39).

 
To describe possible associations between depressive symptomatology and cortisol levels after awakening, first the HDI scores were determined. Analysis revealed a mean HDI score of 8.88, which is slightly lower than the mean score for male college students (9.44) reported by Reynolds and Kobak (40).

Pearson correlations between the total HDI score and the aggregated cortisol response after awakening showed a trend for significance (r = 0.30, p = .06) for the total group (N = 39). There seemed to be a stronger association (r = 0.34, p = .05) when subjects in the subclinical and clinical range of depression were excluded. Figure 2 shows the scatterplot between HDI score and the cortisol response after awakening for the nonclinical group.



View larger version (8K):
[in this window]
[in a new window]
 
Fig. 2. Scattergram of cortisol response to awakening (area under the curve, median for 4 sampling days) plotted against the total score on the Hamilton Depression Inventory. Pearson correlation: r = 0.34, p = .05, N = 33.

 
Subjects were then assigned to groups with low and high depression scores by using a median split for the HDI scores (low: <=7.5; high: >7.5). For the total group, an ANOVA (group by time) revealed a significantly higher cortisol response after awakening in subjects with high HDI scores (F(1,37) = 7.56, p < .01). The group-by-time interaction effect showed a trend to be significant (F(2,74) = 2.91, p = .06). Excluding all subjects in the subclinical and clinical range of depression still resulted in a significant group effect (F(1,31 = 7.26, p = .01). Moreover, a significant group-by-time interaction was observed (F(2,62) = 5.4, p = .007). Post hoc analysis revealed that the cortisol levels 30 and 60 minutes after awakening reflected the group differences best. Figure 3 shows the cortisol levels during the first hour after awakening for the total and nonclinical group in subjects with high and low scores on the HDI.



View larger version (10K):
[in this window]
[in a new window]
 
Fig. 3. Cortisol response during the first hour after awakening (median for 4 weeks) in subjects with high (>7.5) and low (<=7.5) scores on the Hamilton Depression Inventory (HDI). a, Total group. Main effect, p < .01; interaction effect, p = .06. b, Nonclinical group (all subjects in the clinical and subclinical range of depression excluded). Main effect, p = .01; interaction effect, p < .007. Difference according to Newman Keuls post hoc analysis: *p < .01; **p < .001.

 
The total HDI score was significantly correlated with the total score on the TICS (r = 0.67, p < .001) and with scores on the work overload (r = 0.44, p < .01), worries (r = 0.44, p < .01), social stress (r = 0.65, p < .001), lack of recognition (r = 0.59, p < .001), and intrusive memories (r = 0.67, p < .001) subscales, suggesting similarities between the concepts.

Next, associations between chronic stress and the cortisol response after awakening were investigated. Correlational analyses revealed a trend for a significant association between the total score on the TICS and cortisol after awakening (area under the curve, median for 4 weeks: r = 0.31, p < .06). The only subscale that demonstrated a significant association with cortisol was work overload (r = 0.37, p = .02). However, after correcting for the number of comparisons, the result failed to remain significant.

Separating the group by median split according to the subjects’ total score on the stress scale, a two-way ANOVA showed no main effect for the factor group but revealed a significant group-by-time interaction effect (F(2,74) = 3.78, p = .027). Newman-Keuls post hoc analysis revealed significant differences in the cortisol levels 30 minutes after awakening.

Assigning subjects to groups with high and low levels on each of the six subscales again revealed no main effect on cortisol for the factor group. However, for the scale work overload, a significant interaction effect was shown (F(2,74) = 6.78, p = .002); this effect was still significant after adjustment of the significance level according to the number of comparisons. Post hoc analysis revealed significant differences in the cortisol levels at the time of awakening and 30 minutes thereafter. Figure 4 shows the cortisol levels after awakening in the groups with high and low total scores on the TICS and in the groups with high and low scores for work overload.



View larger version (11K):
[in this window]
[in a new window]
 
Fig. 4. Cortisol response during the first hour after awakening (median for 4 weeks). a, Subjects with high and low total scores on the Trier Inventory for the Assessment of Chronic Stress (TICS). Interaction effect of group by time, p < .03. b, Subjects with high and low scores on the subscale work overload. Interaction effect, p = .002. Difference according to Newman Keuls post hoc analysis: *p < .05; **p < .01.

 
Significant associations between the 10-point rating scale for momentary feelings of stress and the HDI were demonstrated by Spearman rank correlations (r = 0.42, p = .008). This result further demonstrates a partial overlap of self-perceived stress and feelings of depression. Also, this measure showed the highest correlation of all stress measures with cortisol levels after awakening (r = 0.46, p = .004; see Fig. 5).



View larger version (12K):
[in this window]
[in a new window]
 
Fig. 5. Scattergram of the cortisol response after awakening (area under the curve, median for 4 sampling days) plotted against the acute stress rating. Spearman correlation: R = 0.46, p < .004.

 

    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The present study examined the relationship between depressive symptomatology, measures of stress, and the cortisol response to awakening in healthy male college students. Most importantly, a positive association between elevated cortisol levels after awakening and the self-reported severity of depressive symptoms could be demonstrated. The present finding differs from earlier studies in several aspects. First, whereas numerous studies in the past reported hypercortisolism in association with clinical depression (1, 2, 44), the present study investigated changes in HPA activation due to differences in the severity of depressive symptoms in a normal population. In contrast to the diagnosis of clinical depression, which regularly is confirmed with a structured clinical interview, the present study assessed the severity of depressive symptomatology with a self-report measure. However, because a clinical interview was not performed, we cannot exclude the possibility that clinically depressed subjects were part of our population. Second, compared with previous studies measuring changes in HPA activation and mood due to predefined situational factors (14, 26, 45, 46), the HDI is believed to measure the severity of depressive symptomatology on a more general level. However, it could be argued that the 2-week period the HDI is referring to is too short to measure depressive symptomatology beyond a state. On the other hand, it must be noted that this reference time is consistent with other self-report measures of depression and the time period of symptom duration in the DSM-IV (40).

Third, cortisol regulation was assessed during 1 hour in the morning with strict reference to the time of awakening. We propose that this method has several advantages compared with traditional approaches determining cortisol regulation. Diurnal assessments of cortisol secretion in depressed patients and control subjects (1621) led to inconsistent results concerning the time of day that best differentiates between groups. Whereas measurement of cortisol levels at predefined times underlies large inter- and intraindividual variation (33), cortisol sampling during the first hour in the morning with strict reference to the time of awakening seems to produce more reliable results (32). Moreover, determining early morning free cortisol in saliva is noninvasive, less time consuming than diurnal sampling, and can be done at home without disturbing individual morning habits.

It was intriguing to find group differences in the cortisol response to awakening already in the nonclinical range of depression. When we included subjects with more severe depressive symptoms according to the HDI, the association with cortisol was less clear than for the nonclinical group alone. The common finding that only a small proportion of clinically depressed subjects reacts with cortisol nonsuppression to the dexamethasone suppression test (6, 7) suggests that clinical depression is characterized by an increased variability of cortisol levels and that additional mechanisms might have an impact on HPA regulation.

Previous reports describing a significant relation between measures of stress and early morning free cortisol (3436) could be confirmed and extended in the current study. Consistent with the results by Schulz et al. (34), the present study reports significantly higher cortisol levels after awakening in subjects with high work overload. Moreover, we observed a significant cortisol difference between subjects with high and low total TICS scores 30 minutes after awakening, a finding that has not been reported before. Differences between our results and those of a previous study in which associations between other TICS subscales and cortisol were found (35) might be explained by the smaller sample size and the restriction to male subjects in the present study. Furthermore, the median cortisol level during a period of 4 weeks (assessed in this study) is expected to better represent baseline HPA activity than measurement on a single day.

Interestingly, the highest correlations of the cortisol response after awakening were found with a 10-point rating scale assessing momentary feelings of stress. Although a simple statement about the level of acute stress is rather unspecific and should not be overinterpreted, this finding points to the relevance of actual mood variations in determining cortisol differences. The observed correlation between measures of chronic stress and depressive symptomatology confirms similar evidence from other studies (4750). The association between the acute stress measure and the HDI score was even stronger. It can be argued that the time frame both scales are referring to is overlapping. Thus, the acute stress measure might have better reflected the subject’s actual situation than the TICS, which is referring to the past year.

We can only speculate about the causal relationship between stress, depression, and elevated cortisol levels, but a mediating role of life stressors for the development of depressive illness has been suggested (51, 52). The underlying dysregulations of the HPA axis in depression and chronic stress states seem to follow a similar pattern. Both conditions are characterized by increases in cortisol secretion, and in both conditions, increased central drive, impaired glucocorticoid feedback, and hypertrophy of the adrenal gland have been observed (3, 4). The consistent coappearance of hypercortisolism and depression led several authors to suggest that elevated cortisol levels cause depressive symptoms (1, 53, 54). Additional evidence for such a relationship comes from studies reporting that depressive symptomatology seems to be reversible by antiglucocorticoid therapy and antidepressant actions on HPA regulation (1, 4, 5557).

Future studies still need to compare the usefulness of measuring the cortisol response to awakening with traditional approaches to assess HPA dysregulations. It will be particularly interesting to investigate if the proposed method is applicable for patients with clinical depression. Furthermore, subsequent studies should include more detailed questionnaires assessing the association between acute stress perception and the cortisol response to awakening. In light of the higher prevalence of depressive symptomatology in women (58), it would also be interesting to include both genders in similar investigations in the future.

Received for publication May 17, 2001.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. O’Brien JT, Ames D, Schweitzer I. HPA axis function in depression and dementia: a review. Int J Geriatr Psychiatry 1993; 8: 887–98.[CrossRef]
  2. Plotsky PM, Owens MJ, Nemeroff CB. Psychoneuroendocrinology of depression: hypothalamic-pituitary-adrenal axis. Psychiatr Clin North Am 1998; 21: 293–307.[CrossRef][Medline]
  3. Checkley S. The neuroendocrinology of depression and chronic stress. Br Med Bull 1996; 52: 597–617.[Abstract/Free Full Text]
  4. Holsboer F, Barden N. Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocr Rev 1996; 17: 187–205.[CrossRef][Medline]
  5. Modell S, Yassouridis A, Huber J, Holsboer F. Corticosteroid receptor function is decreased in depressed patients. Neuroendocrinology 1997; 65: 216–22.[Medline]
  6. Carroll BJ, Curtis GC, Mendels J. Neuroendocrine regulation in depression. II. Discrimination of depressed from nondepressed patients. Arch Gen Psychiatry 1976; 33: 1051–8.[Abstract]
  7. Carroll BJ. Problems with diagnostic criteria for depression. J Clin Psychiatry 1984; 45: 14–8.
  8. Nemeroff CB, Krishnan KR, Reed D, Leder R, Beam C, Dunnick NR. Adrenal gland enlargement in major depression: a computed tomographic study. Arch Gen Psychiatry 1992; 49: 384–7.[Abstract]
  9. Rubin RT, Phillips JJ, Sadow TF, McCracken JT. Adrenal gland volume in major depression: increase during the depressive episode and decrease with successful treatment. Arch Gen Psychiatry 1995; 52: 213–8.[Abstract]
  10. Kelly WF, Checkley SA, Bender DA, Mashiter K. Cushing’s syndrome and depression—a prospective study of 26 patients. Br J Psychiatry 1983; 142: 16–9.[Abstract/Free Full Text]
  11. Starkman MN, Schteingart DE, Schork MA. Depressed mood and other psychiatric manifestations of Cushing’s syndrome: relationship to hormone levels. Psychosom Med 1981; 43: 3–18.[Abstract/Free Full Text]
  12. Loosen PT, Chambliss B, DeBold CR, Shelton R, Orth DN. Psychiatric phenomenology in Cushing’s disease. Pharmacopsychiatry 1992; 25: 192–8.[Medline]
  13. Fassbender K, Schmidt R, Mossner R, Kischka U, Kuhnen J, Schwartz A, Hennerici M. Mood disorders and dysfunction of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: association with cerebral inflammation. Arch Neurol 1998; 55: 66–72.[Abstract/Free Full Text]
  14. Taylor A, Littlewood J, Adams D, Dore C, Glover V. Serum cortisol levels are related to moods of elation and dysphoria in new mothers. Psychiatry Res 1994; 54: 241–7.[CrossRef][Medline]
  15. Singh B, Gilhotra M, Smith R, Brinsmead M, Lewin T, Hall C. Post-partum psychoses and the dexamethasone suppression test. J Affect Disord 1986; 11: 173–7.[CrossRef][Medline]
  16. Halbreich U, Asnis GM, Shindledecker R, Zumoff B, Nathan RS. Cortisol secretion in endogenous depression. I. Basal plasma levels. Arch Gen Psychiatry 1985; 42: 904–8.[Abstract]
  17. Maes M, De Ruyter M, Hobin P, Suy E. The dexamethasone suppression test, the Hamilton Depression Rating Scale and the DSM-III depression categories. J Affect Disord 1986; 10: 207–14.[CrossRef][Medline]
  18. Asnis GM, Sachar EJ, Halbreich U, Nathan RS, Ostrow L, Halpern FS. Cortisol secretion and dexamethasone response in depression. Am J Psychiatry 1981; 138: 1218–21.[Abstract/Free Full Text]
  19. Dahl RE, Ryan ND, Puig-Antich J, Nguyen NA, al-Shabbout M, Meyer VA, Perel J. 24-Hour cortisol measures in adolescents with major depression: a controlled study. Biol Psychiatry 1991; 30: 25–36.[CrossRef][Medline]
  20. Trestman RL, Yehuda R, Coccaro E, Horvath T, Knott P, Gabriel S, Siever LJ. Diurnal neuroendocrine and autonomic function in acute and remitted depressed male patients. Biol Psychiatry 1995; 37: 448–56.[CrossRef][Medline]
  21. Yehuda R, Teicher MH, Trestman RL, Levengood RA, Siever LJ. Cortisol regulation in posttraumatic stress disorder and major depression: a chronobiological analysis. Biol Psychiatry 1996; 40: 79–88.[CrossRef][Medline]
  22. Carroll BJ, Curtis GC, Davies BM, Mendels J, Sugerman AA. Urinary free cortisol excretion in depression. Psychol Med 1976; 6: 43–50.[Medline]
  23. Rubin RT, Poland RE, Lesser IM, Winston RA, Blodgett AL. Neuroendocrine aspects of primary endogenous depression. I. Cortisol secretory dynamics in patients and matched controls. Arch Gen Psychiatry 1987; 44: 328–36.[Abstract]
  24. von Zerssen D, Doerr P, Emrich HM, Lund R, Pirke KM. Diurnal variation of mood and the cortisol rhythm in depression and normal states of mind. Eur Arch Psychiatry Neurol Sci 1987; 237: 36–45.[CrossRef][Medline]
  25. Goodyer IM, Herbert J, Altham PM, Pearson J, Secher SM, Shiers HM. Adrenal secretion during major depression in 8- to 16-year-olds. I. Altered diurnal rhythms in salivary cortisol and dehydroepiandrosterone (DHEA) at presentation. Psychol Med 1996; 26: 245–56.[Medline]
  26. Ockenfels MC, Porter L, Smyth J, Kirschbaum C, Hellhammer DH, Stone AA. Effect of chronic stress associated with unemployment on salivary cortisol: overall cortisol levels, diurnal rhythm, and acute stress reactivity. Psychosom Med 1995; 57: 460–7.[Abstract]
  27. van Eck M, Berkhof H, Nicolson N, Sulon J. The effects of perceived stress, traits, mood states, and stressful daily events on salivary cortisol. Psychosom Med 1996; 58: 447–58.[Abstract/Free Full Text]
  28. Gold PW, Goodwin FK, Chrousos GP. Clinical and biochemical manifestations of depression: relation to the neurobiology of stress. N Engl J Med 1988; 319: 348–353, 413–420.[Abstract]
  29. Linkowski P, Van Onderbergen A, Kerkhofs M, Bosson D, Mendlewicz J, Van Cauter E. Twin study of the 24-h cortisol profile: evidence for genetic control of the human circadian clock. Am J Physiol 1993; 264(2 Pt 1): E173–81.[Abstract/Free Full Text]
  30. Spath Schwalbe E, Gofferje M, Kern W, Born J, Fehm HL. Sleep disruption alters nocturnal ACTH and cortisol secretory patterns. Biol Psychiatry 1991; 29: 575–84.[CrossRef][Medline]
  31. Van Cauter EV, Polonsky KS, Blackman JD, Roland D, Sturis J, Byrne MM, Scheen AJ. Abnormal temporal patterns of glucose tolerance in obesity: relationship to sleep-related growth hormone secretion and circadian cortisol rhythmicity. J Clin Endocrinol Metab 1994; 79: 1797–805.[Abstract]
  32. Pruessner JC, Wolf OT, Hellhammer DH, Buske-Kirschbaum A, von Auer K, Jobst S, Kaspers F, Kirschbaum C. Free cortisol levels after awakening: a reliable biological marker for the assessment of adrenocortical activity. Life Sci 1997; 61: 2539–49.[CrossRef][Medline]
  33. Coste J, Strauch G, Letrath M, Bertagna X. Reliability of hormonal levels for assessing the hypothalamic-pituitary-adrenocortical system in clinical pharmacology. Br J Clin Pharmacol 1994; 38: 474–9.[Medline]
  34. Schulz P, Kirschbaum C, Pruessner J, Hellhammer D. Increased free cortisol secretion after awakening in chronically stressed individuals due to work overload. Stress Med 1998; 14: 91–7.
  35. Wust S, Federenko I, Hellhammer DH, Kirschbaum C. Genetic factors, perceived chronic stress, and the free cortisol response to awakening. Psychoneuroendocrinology 2000; 25: 707–20.[CrossRef][Medline]
  36. Pruessner JC, Hellhammer DH, Kirschbaum C. Burnout, perceived stress, and cortisol responses to awakening. Psychosom Med 1999; 61: 197–204.[Abstract/Free Full Text]
  37. Geiss A, Varadi E, Steinbach K, Bauer HW, Anton F. Psychoneuroimmunological correlates of persisting sciatic pain in patients who underwent discectomy. Neurosci Lett 1997; 237: 65–8.[CrossRef][Medline]
  38. Kirschbaum C, Kudielka BM, Gaab J, Schommer NC, Hellhammer DH. Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamus-pituitary-adrenal axis. Psychosom Med 1999; 61: 154–62.[Abstract/Free Full Text]
  39. Kirschbaum C, Hellhammer DH. Salivary cortisol in psychoneuroendocrine research: recent developments and applications. Psychoneuroendocrinology 1994; 19: 313–33.[CrossRef][Medline]
  40. Reynolds WM, Kobak KA. Hamilton Depression Inventory: a self-report version of the Hamilton Depression Rating Scale. Odessa (FL): Psychological Assessment Resources; 1995.
  41. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6: 278–96.[Medline]
  42. Schulz P, Schlotz W. The Trier Inventory for the Assessment of Chronic Stress (TICS): scale construction, statistical testing, and validation of the scale work overload. Diagnostica 1999; 45: 8–19.[CrossRef]
  43. Dressendorfer RA, Kirschbaum C, Rohde W, Stahl F, Strasburger CJ. Synthesis of a cortisol-biotin conjugate and evaluation as a tracer in an immunoassay for salivary cortisol measurement. J Steroid Biochem Mol Biol 1992; 43: 683–92.[CrossRef][Medline]
  44. Murphy BE. Steroids and depression. J Steroid Biochem Mol Biol 1991; 38: 537–59.[CrossRef][Medline]
  45. McCleery JM, Bhagwagar Z, Smith KA, Goodwin GM, Cowen PJ. Modelling a loss event: effect of imagined bereavement on the hypothalamic-pituitary-adrenal axis. Psychol Med 2000; 30: 219–23.[CrossRef][Medline]
  46. O’Connor PJ, Morgan WP, Raglin JS, Barksdale CM, Kalin NH. Mood state and salivary cortisol levels following overtraining in female swimmers. Psychoneuroendocrinology 1989; 14: 303–10.[CrossRef][Medline]
  47. Bifulco A, Bernazzani O, Moran PM, Ball C. Lifetime stressors and recurrent depression: preliminary findings of the Adult Life Phase Interview (ALPHI). Soc Psychiatry Psychiatr Epidemiol 2000; 35: 264–75.[CrossRef][Medline]
  48. Breslau N, Davis GC. Chronic stress and major depression. Arch Gen Psychiatry 1986; 43: 309–14.[Abstract]
  49. Krause N. Life stress as a correlate of depression among older adults. Psychiatry Res 1986; 18: 227–37.[CrossRef][Medline]
  50. Phelan J, Schwartz JE, Bromet EJ, Dew MA, Parkinson DK, Schulberg HC, Dunn LO, Blane H, Curtis EC. Work stress, family stress and depression in professional and managerial employees. Psychol Med 1991; 21: 999–1012.[Medline]
  51. Bifulco A, Bernazzani O, Moran PM, Ball C. Lifetime stressors and recurrent depression: preliminary findings of the Adult Life Phase Interview (ALPHI). Soc Psychiatry Psychiatr Epidemiol 2000; 35: 264–75.
  52. Brugha TS, Bebbington PE, Stretch DD, MacCarthy B, Wykes T. Predicting the short-term outcome of first episodes and recurrences of clinical depression: a prospective study of life events, difficulties, and social support networks. J Clin Psychiatry 1997; 58: 298–306.[Medline]
  53. Checkley S. Neuroendocrine mechanisms and the precipitation of depression by life events. Br J Psychiatry Suppl 1992; (15): 7–17.
  54. Stokes PE. The potential role of excessive cortisol induced by HPA hyperfunction in the pathogenesis of depression. Eur Neuropsychopharmacol 1995; 5: 77–82.
  55. Barden N, Reul JM, Holsboer F. Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system? Trends Neurosci 1995; 18: 6–11.[CrossRef][Medline]
  56. Murphy BE, Dhar V, Ghadirian AM, Chouinard G, Keller R. Response to steroid suppression in major depression resistant to antidepressant therapy. J Clin Psychopharmacol 1991; 11: 121–6.[Medline]
  57. Wolkowitz OM, Reus VI, Chan T, Manfredi F, Raum W, Johnson R, Canick J. Antiglucocorticoid treatment of depression: double-blind ketoconazole. Biol Psychiatry 1999; 45: 1070–4.[CrossRef][Medline]
  58. Piccinelli M, Wilkinson G. Gender differences in depression: critical review. Br J Psychiatry 2000; 177: 486–92.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
U. M. Nater, E. Maloney, R. S. Boneva, B. M. Gurbaxani, J.-M. Lin, J. F. Jones, W. C. Reeves, and C. Heim
Attenuated Morning Salivary Cortisol Concentrations in a Population-Based Study of Persons with Chronic Fatigue Syndrome and Well Controls
J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 703 - 709.
[Abstract] [Full Text] [PDF]


Home page
West J Nurs ResHome page
S. M. Kneipp, D. P. Welch, C. E. Wood, C. B. Yucha, and H. Yarandi
Psychosocial and Physiological Stress Among Women Leaving Welfare
West J Nurs Res, November 1, 2007; 29(7): 864 - 883.
[Abstract] [PDF]


Home page
Am. J. PsychiatryHome page
Z. N. Mannie, C. J. Harmer, and P. J. Cowen
Increased Waking Salivary Cortisol Levels in Young People at Familial Risk of Depression
Am J Psychiatry, April 1, 2007; 164(4): 617 - 621.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. H. Golden, S. Malhotra, G. S. Wand, F. L. Brancati, D. Ford, and K. Horton
Adrenal Gland Volume and Dexamethasone-Suppressed Cortisol Correlate with Total Daily Salivary Cortisol in African-American Women
J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1358 - 1363.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. K. Adam, L. C. Hawkley, B. M. Kudielka, and J. T. Cacioppo
Day-to-day dynamics of experience-cortisol associations in a population-based sample of older adults
PNAS, November 7, 2006; 103(45): 17058 - 17063.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
S. Cohen, J. E. Schwartz, E. Epel, C. Kirschbaum, S. Sidney, and T. Seeman
Socioeconomic Status, Race, and Diurnal Cortisol Decline in the Coronary Artery Risk Development in Young Adults (CARDIA) Study
Psychosom Med, January 1, 2006; 68(1): 41 - 50.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
M. Heinrichs, D. Wagner, W. Schoch, L. M. Soravia, D. H. Hellhammer, and U. Ehlert
Predicting Posttraumatic Stress Symptoms From Pretraumatic Risk Factors: A 2-Year Prospective Follow-Up Study in Firefighters
Am J Psychiatry, December 1, 2005; 162(12): 2276 - 2286.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
A. Steptoe, L. Brydon, and S. Kunz-Ebrecht
Changes in Financial Strain Over Three Years, Ambulatory Blood Pressure, and Cortisol Responses to Awakening
Psychosom Med, March 1, 2005; 67(2): 281 - 287.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
J HELLHAMMER, W SCHLOTZ, A A STONE, K M PIRKE, and D HELLHAMMER
Allostatic Load, Perceived Stress, and Health: A Prospective Study in Two Age Groups
Ann. N.Y. Acad. Sci., December 1, 2004; 1032(1): 8 - 13.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
A. Steptoe, J. Siegrist, C. Kirschbaum, and M. Marmot
Effort--Reward Imbalance, Overcommitment, and Measures of Cortisol and Blood Pressure Over the Working Day
Psychosom Med, May 1, 2004; 66(3): 323 - 329.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pruessner, M.
Right arrow Articles by Lupien, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pruessner, M.
Right arrow Articles by Lupien, S. J.
Related Collections
Right arrow Neuroendocrine
Right arrow Sleep and Biological Rhythms
Right arrow Stress and Coping


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS